glp-1 substance abuse Frontiers GLP-1 and Anesthesia: Considerations and

It is important to note that at the beginning of each study, researchers should start with a low daily dose and increase the liraglutide dosage over the course of five weeks to prevent side effects

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity medicalxpress.com To view or add a comment, sign in FDA Approval Update: Foundayo (orforglipron) On April 1, 2026, the U.S

Creation of an anti-inflammatory, leptin-dependent anti-obesity celastrol mimic with better druggability

Our write-up above is an editorial review, not a medical recommendation

Sildenafil and other phosphodiesterase-5 inhibitors have shown promise in mitigating doxorubicin-induced cardiotoxicity

Secukinumab efficacy in patients with psa is not dependent on patients body mass index